HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A remote household-based approach to influenza self-testing and antiviral treatment.

AbstractBACKGROUND:
Households represent important settings for transmission of influenza and other respiratory viruses. Current influenza diagnosis and treatment relies upon patient visits to healthcare facilities, which may lead to under-diagnosis and treatment delays. This study aimed to assess the feasibility of an at-home approach to influenza diagnosis and treatment via home testing, telehealth care, and rapid antiviral home delivery.
METHODS:
We conducted a pilot interventional study of remote influenza diagnosis and treatment in Seattle-area households with children during the 2019-2020 influenza season using pre-positioned nasal swabs and home influenza tests. Home monitoring for respiratory symptoms occurred weekly; if symptoms were reported within 48 hours of onset, participants collected mid-nasal swabs and used a rapid home-based influenza immunoassay. An additional home-collected swab was returned to a laboratory for confirmatory influenza RT-PCR testing. Baloxavir antiviral treatment was prescribed and delivered to symptomatic and age-eligible participants, following a telehealth encounter.
RESULTS:
124 households comprising 481 individuals self-monitored for respiratory symptoms, with 58 home tests administered. 12 home tests were positive for influenza, of which eight were true positives confirmed by RT-PCR. The sensitivity and specificity of the home influenza test were 72.7% and 96.2%, respectively. There were eight home deliveries of baloxavir, with 7 (87.5%) occurring within 3 hours of prescription and all within 48 hours of symptom onset.
CONCLUSIONS:
We demonstrate the feasibility of self-testing combined with rapid home delivery of influenza antiviral treatment. This approach may be an important control strategy for influenza epidemics and pandemics.
AuthorsJessica Heimonen, Denise J McCulloch, Jessica O'Hanlon, Ashley E Kim, Anne Emanuels, Naomi Wilcox, Elisabeth Brandstetter, Mark Stewart, David McCune, Scott Fry, Sean Parsons, James P Hughes, Michael L Jackson, Timothy M Uyeki, Michael Boeckh, Lea M Starita, Trevor Bedford, Janet A Englund, Helen Y Chu
JournalInfluenza and other respiratory viruses (Influenza Other Respir Viruses) Vol. 15 Issue 4 Pg. 469-477 (07 2021) ISSN: 1750-2659 [Electronic] England
PMID33939275 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Copyright© 2021 The Authors. Influenza and Other Respiratory Viruses published by John Wiley & Sons Ltd.
Chemical References
  • Antiviral Agents
Topics
  • Antiviral Agents (therapeutic use)
  • Child
  • Humans
  • Influenza, Human (diagnosis, drug therapy, epidemiology)
  • Pandemics
  • Self-Testing
  • Sensitivity and Specificity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: